2DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med, 1980,303:897-902.
3Eagle KA, NaIIamothu BK, Mehta RH, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J, 2008 ,29 :609-617.
4Fassa AA, Urban P, Radovanovic D, et al. AMIS Plus Investigators. Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland : six year results from a nationwide registry. Heart, 2005, 91:882-888.
5Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over I. 5 million patients with myocardial infarction in the US from 1990 through 1999.. the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coil Cardiol, 2000, 36: 2056-2063.
6Fox KA, Goodman SG, Anderson FA Jr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events ( GRACE ). Eur Heart J, 2003,24 : 1414 -1424.
7Fox KA, Cokkinos DV, Deckers J, et al. The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J, 2000, 21 : 1440-1449.
8Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro heart survey ACS). Eur Heart J, 2002, 23:1190-1201.
9Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet, 2005, 366: 1607- 1621.
2Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention ( ASSENT-4 PCI ) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction ( ASSENT-4 PCI ) : randomised trial. Lancet. 2006. 367:569-578.
3,llis SG, Tendera M, de Belder MA, et al. Facilitated PCI in atients with ST-elevation myocardial infarction. N Engl J Med, 908, 358 : 2205-2217.
4Wijeysundera HC, You JJ, Nallamothu BK, et al. An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials. Am Heart J, 2008, 156:564-572.
5Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996, 17:1-12.
6Higgins JP, Thompson SG. Quantifying heterogeneity in a meta- analysis. Stat Med, 2002,21:1539-1558.
7Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J, 2000.21:823-831.
8] Scheller B, Hennen B, Hammer B, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coil Cardiol,2003, 42:634-641.
9Femandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia- guided conservative approach for acute myocardial infarction with ST-segment elevation ( GRACIA-1 ) : a randomised controlled trial. Lancet, 2004,364 : 1045-1053.
10Le May MR, Wells GA, Labinaz M, et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acutemyocardial infarction (CAPITAL AMI study). J Am Coil Cardiol, 2005,46:417-424.
